Milestone Pharmaceuticals (MIST) Depreciation & Amortization (CF) (2018 - 2026)
Milestone Pharmaceuticals (MIST) posted Depreciation & Amortization (CF) of $56000.0 for Q1 2026, up 64.71% on a QoQ basis from $34000.0 in Q4 2025, and up 107.41% year-over-year from $27000.0 in Q1 2025.
Milestone Pharmaceuticals (MIST) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Milestone Pharmaceuticals' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $56000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 107.41% year-over-year to $56000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143000.0 (up 37.5% YoY) and the FY2025 annual result came in at $114000.0, up 8.57% from the prior year.
- Depreciation & Amortization (CF) was $56000.0 for Q1 2026 at Milestone Pharmaceuticals, up from $34000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $56000.0 in Q1 2026 and bottomed at $15000.0 in Q4 2022.
- A 5-year average of $26823.5 and a median of $26000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slumped 34.78% — and 2026, when it jumped 107.41%.
- Milestone Pharmaceuticals' Depreciation & Amortization (CF) stood at $15000.0 in 2022, then surged by 73.33% to $26000.0 in 2023, then changed by 0.0% to $26000.0 in 2024, then surged by 30.77% to $34000.0 in 2025, then jumped by 64.71% to $56000.0 in 2026.
- Business Quant data shows MIST's Depreciation & Amortization (CF) at $56000.0 in Q1 2026, $34000.0 in Q4 2025, and $25000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Milestone Pharmaceuticals | 156.34 Mn | -27.87 Mn | - | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Sep 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Jun 30, 2024 | 26,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Mar 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |